ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 53 filers reported holding ONCTERNAL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,953 | -12.1% | 161,401 | 0.0% | 0.00% | – |
Q2 2023 | $55,683 | -56.1% | 161,401 | 0.0% | 0.00% | – |
Q1 2023 | $126,700 | -60.7% | 161,401 | -50.0% | 0.00% | – |
Q4 2022 | $322,802 | +124.2% | 322,802 | +100.0% | 0.00% | – |
Q3 2022 | $144,000 | -37.1% | 161,401 | -21.8% | 0.00% | – |
Q2 2022 | $229,000 | -80.9% | 206,501 | -76.1% | 0.00% | – |
Q1 2022 | $1,202,000 | -38.4% | 864,881 | +0.6% | 0.00% | – |
Q4 2021 | $1,951,000 | -42.1% | 859,567 | +6.4% | 0.00% | – |
Q3 2021 | $3,368,000 | -3.0% | 807,637 | +10.5% | 0.00% | – |
Q2 2021 | $3,473,000 | +2057.1% | 731,191 | +3685.8% | 0.00% | – |
Q1 2021 | $161,000 | +83.0% | 19,314 | +7.8% | 0.00% | – |
Q4 2020 | $88,000 | +193.3% | 17,914 | 0.0% | 0.00% | – |
Q3 2020 | $30,000 | -50.8% | 17,914 | -16.4% | 0.00% | – |
Q2 2020 | $61,000 | -10.3% | 21,428 | -8.0% | 0.00% | – |
Q1 2020 | $68,000 | -26.1% | 23,299 | 0.0% | 0.00% | – |
Q4 2019 | $92,000 | -31.3% | 23,299 | -13.2% | 0.00% | – |
Q3 2019 | $134,000 | -25.6% | 26,827 | -0.6% | 0.00% | – |
Q2 2019 | $180,000 | – | 26,998 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 360,000 | $1,710,000 | 0.88% |
APIS CAPITAL ADVISORS, LLC | 120,000 | $570,000 | 0.49% |
Parkman Healthcare Partners LLC | 415,384 | $1,973,000 | 0.43% |
Altium Capital Management LP | 172,218 | $818,000 | 0.19% |
Vigilare Wealth Management | 52,535 | $250,000 | 0.15% |
BRIGHTON JONES LLC | 332,875 | $1,581,000 | 0.08% |
Ikarian Capital, LLC | 200,204 | $950,000 | 0.08% |
IPG Investment Advisors LLC | 31,106 | $147,754,000 | 0.04% |
DOWLING & YAHNKE LLC | 150,464 | $715,000 | 0.04% |
Jump Financial, LLC | 58,225 | $276,000 | 0.03% |